Drawing based on the label description. No photo yet.
“25 mg tablets white, oval, biconvex, scored on both sides, film-coated tablet engraved with "N / 25"”
N 25 pill
Pill with imprint N 25 is white, oval, 9 mm and has been identified as Metoprolol Succinate 25 mg. It is used for high blood pressure, heart failure and chest pain (angina). It is supplied by Aphena Pharma Solutions - Tennessee, LLC.
Metoprolol Succinate 25 mg
- Imprint
- N 25
- Strength
- 25 mg
- Used for
- High blood pressure, heart failure and chest pain (angina)
- Color
- White
- Shape
- Oval
- Size
- 9 mm
- Score
- Breaks into 2 pieces
- Form
- Tablet, extended release
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Drug class
- Beta blocker (heart and blood pressure medicine)
- NDC
- 71610-555, 51407-403, 71610-555-45, 71610-555-60, 71205-350, 50742-615, 71205-350-30, 71205-350-60, 71205-350-90, 61919-754, 61919-754-90, 61919-754-30, 68001-356, 68001-356-00, 68001-356-03, 50742-615-90, 50742-615-01, 50742-615-99, 50742-615-05, 50742-615-10, 51407-403-01, 51407-403-10, 67046-0883, 67046-0883-3
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Metoprolol Succinate used for?
Metoprolol Succinate is used for high blood pressure, heart failure, chest pain (angina) and atrial fibrillation (irregular heartbeat).
- Medicine type
- Beta blocker (heart and blood pressure medicine)
Official uses from the US prescribing label
Hypertension
Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Metoprolol succinate extended-release tablets may be administered with other antihypertensive agents.
Angina Pectoris
Metoprolol succinate extended-release tablets are indicated in the long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance.
Heart Failure
Metoprolol succinate extended-release tablets are indicated to reduce the risk of cardiovascular mortality and heart-failure hospitalization in patients with heart failure.
From the FDA-approved label on DailyMed (published Sep 18, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows N 25. The parts can be split between the two sides, so turn the pill over and check both.
- It is white, oval, 9 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Metoprolol Succinate
Inactive: Magnesium Stearate, Cellulose, Microcrystalline, Titanium Dioxide, Polydextrose, Hypromelloses, Triacetin, Povidone, Ethylcelluloses, Polyethylene Glycol 3350, Hydroxypropyl Cellulose, Triethyl Citrate
Also distributed by
Proficient Rx LP, Direct_rx, Bluepoint Laboratories, Ingenus Pharmaceuticals, LLC, Golden State Medical Supply, Inc., Coupler LLC
Other pills with imprint N 2 5
Same imprint, different listing. Check the color, size and maker against your pill.
- N 25 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- N 2 5 Naratriptan 2.5 mg Green, capsule, 13 mm Used for migraine
- n 25 Oxycodone Hydrochloride 10 mg Gray, round, 7 mm Used for postoperative pain Schedule II
- N 25 Sildenafil Citrate 25 mg Blue, diamond Used for high blood pressure in the lungs and vasculogenic impotence
- N 25 Sildenafil Citrate 25 mg Blue, diamond Used for high blood pressure in the lungs and vasculogenic impotence
- N 25 Sildenafil Citrate 25 mg Blue, diamond Used for high blood pressure in the lungs and vasculogenic impotence
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
EC
Enalapril Maleate 2.5 mg
White, oval, 8 mm
Used for severe high blood pressure and heart failure
-
R 2 5 0163
Olanzapine 2.5 mg
White, oval, 8 mm
Used for bipolar disorder and schizophrenia
-
C 2
Clobazam 10 mg
White, oval, 9 mm
Used for seizures
Schedule IV
-
SAV 001
Sacubitril and Valsartan 24 mg / 26 mg
White, oval, 9 mm
Used for heart failure
-
G Breakline G
Levocetirizine Dihydrochloride 5 mg
White, oval, 8 mm
Used for hay fever and year-round allergies
-
3 0 1104
Isosorbide Mononitrate 30 mg
White, oval, 9 mm
Used for heart failure and chest pain (angina)
Other Metoprolol Succinate pills
-
M 3
Metoprolol Succinate 100 mg
White, round, 11 mm
Used for high blood pressure and heart failure
-
M 1
Metoprolol Succinate 25 mg
White, oval, 10 mm
Used for high blood pressure and heart failure
-
M 2
Metoprolol Succinate 50 mg
White, round, 9 mm
Used for high blood pressure and heart failure
- 832 Metoprolol Succinate 100 mg White, round, 10 mm Used for high blood pressure and heart failure
- E283 Metoprolol Succinate 100 mg White, capsule, 14 mm Used for high blood pressure and heart failure
- W 736 Metoprolol Succinate 100 mg White, round, 12 mm Used for high blood pressure and heart failure
- RL16 Metoprolol Succinate 100 mg White, capsule, 18 mm Used for high blood pressure and heart failure
- N 100 Metoprolol Succinate 100 mg White, round, 10 mm Used for high blood pressure and heart failure